Pharmacologic Augmentation of TMS for Depression With D-serine
NCT: NCT06876129 · RECRUITING
広告
NCT識別子NCT06876129
ステータスRECRUITING
開始日2025-04-01
完了2027-04-01
SponsorMclean Hospital (OTHER)
First posted
Last updated
概要
The goal of this study is to test whether combining D-serine with 30 treatments of a) iTBS and b) 18-Hz protocols will enhance clinical outcomes compared to rTMS with placebo (i.e., sugar pill). The investigators hypothesize that NMDA receptor activation via D-serine combined with repeated sessions of rTMS will produce greater clinical outcomes than iTBS with placebo and 18-Hz with placebo.
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。